Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Orange SA | 4.62% | $6.71M | $52.77B | 75.47% | 63 Neutral | |
| GlaxoSmithKline | 4.47% | $6.50M | $123.00B | 64.64% | 77 Outperform | |
| BNP Paribas | 3.78% | $5.49M | $122.41B | 52.04% | 72 Outperform | |
| Reckitt Benckiser Group | 3.65% | $5.31M | $56.11B | 25.56% | 78 Outperform | |
| Royal KPN | 3.48% | $5.05M | $20.66B | 48.90% | 68 Neutral | |
| Enel SpA Unsponsored ADR | 3.42% | $4.96M | $110.95B | 54.33% | 71 Outperform | |
| Petroleo Brasileiro SA- Petrobras | 3.34% | $4.85M | $95.23B | 5.63% | 69 Neutral | |
| TSMC | 3.22% | $4.68M | $1.57T | 80.10% | 81 Outperform | |
| British American Tobacco | 3.09% | $4.49M | $126.61B | 58.21% | 59 Neutral | |
| Rio Tinto | 2.83% | $4.11M | $167.64B | 49.85% | 80 Outperform |